Ad
related to: novavax vaccine
Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 1 day agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 1 day agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 1 day agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 1 day agoThe agreement will also provide Sanofi with a sole license to the vaccine for use in combination...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 1 day agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...